Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
High-Sensitivity Troponin T and Incident Heart Failure in Older Men: British Regional Heart Study
Paul Welsh1, Olia Papacosta2, Sheena Ramsay3
1BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Insights
High-sensitivity troponin T (hsTnT) is linked to heart failure (HF) risk in older men. However, hsTnT does not enhance HF prediction when N-terminal pro-B-type natriuretic peptide is already included.
Area of Science:
- Cardiology
- Biomarkers
- Epidemiology
Background:
- Heart failure (HF) is a significant public health concern.
- Biomarkers like high-sensitivity troponin T (hsTnT) are being investigated for their role in predicting cardiovascular events.
- Understanding the predictive value of hsTnT for incident HF is crucial for refining risk assessment strategies.
Purpose of the Study:
- To investigate the association between hsTnT levels and the incidence of HF in older men.
- To evaluate the added value of hsTnT in HF prediction models, particularly when N-terminal pro-B-type natriuretic peptide (NT-proBNP) is already considered.
Main Methods:
- The British Regional Heart Study cohort, comprising 3852 men aged 60-79 years without baseline HF, was followed for a median of 12.6 years.
- Incident HF cases were identified, and the association between hsTnT and HF risk was analyzed using Cox proportional hazards models, adjusting for traditional risk factors and NT-proBNP.
- The predictive performance of risk models with and without hsTnT was assessed using the C-index.
Main Results:
- A 1-SD increase in hsTnT was associated with a 58% higher risk of incident HF (HR 1.58) after adjusting for classic risk factors, and a 34% higher risk after further adjustment for NT-proBNP (HR 1.34).
- The predictive value of hsTnT did not vary across different risk factor strata.
- While a low hsTnT (<5ng/L) showed high sensitivity for ruling out HF, adding hsTnT to a model with NT-proBNP did not significantly improve HF prediction (P = 0.28).
Conclusions:
- Elevated hsTnT is consistently associated with an increased risk of incident HF in older men.
- HF incidence was low in men with hsTnT below the limit of detection.
- hsTnT measurement does not improve HF prediction when NT-proBNP is already incorporated into the risk model.
Objective:
The aim of this work was to study the association of high-sensitivity troponin T (hsTnT) with incident heart failure (HF), and implications for its use in prediction models.
Methods And Results:
In the British Regional Heart Study, 3852 men aged 60-79years without baseline HF (3165 without baseline chronic heart disease) were followed for a median of 12.6years, during which 295 incident cases of HF occurred (7.7%). A 1-SD increase in log-transformed hsTnT was associated with a higher risk of incident HF after adjusting for classic risk factors (hazard ratio [HR] 1.58, 95% confidence interval [CI] 1.42-1.77) and after additional adjustment for N-terminal pro-B-type natriuretic peptide (NT-proBNP; HR 1.34, 95% CI 1.19-1.52). The strength of the association between hsTnT and incident HF did not differ by strata of other risk factors. An hsTnT concentration of <5ng/L had a sensitivity of 99.7% (95% CI 98.1%-99.9%) and a specificity of 3.4% (95% CI 2.8%-4.0%). A risk-prediction model including classic risk factors and NT-proBNP yielded a C-index of 0.791, but addition of hsTnT did not further improve prediction (P = .28).
Conclusions:
Elevated hsTnT is consistently associated with risk of HF in older men. HF occurred rarely over 12years when baseline hsTnT was below the limit of detection. hsTnT measurement, however, does not improve HF prediction in a model already containing NT-proBNP.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management

